Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shengjia Gene, officially known as Beijing Shengjia Biotechnology, is a high-tech enterprise specializing in the research, development, and commercialization of molecular diagnostic products. The company focuses on providing comprehensive solutions for clinical diagnosis, including reagents and instruments for infectious disease testing, genetic screening, and personalized medicine. Their product portfolio primarily utilizes PCR and sequencing technologies to address needs in reproductive health, oncology, and pathogen detection. Shengjia Gene operates with a strong emphasis on quality control and has established a significant presence in the Chinese domestic diagnostic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 圣嘉.